|
Q3 2021
Filed on Nov 05, 2021
|
527
|
N/A
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
265
|
$5.51 - $9.54
$1.46K - $2.53K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
146
|
$27.02 - $27.59
$3.94K - $4.03K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
100
|
$2.33 - $14.36
$233 - $1.44K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
7
|
N/A
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
250
|
$57.18 - $84.43
$14.3K - $21.1K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
3,477
|
N/A
|
|
Invesco Dynamic Cr Opportuni
|
Q3 2021
Filed on Nov 05, 2021
|
972
|
N/A
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
227
|
$53.06 - $53.38
$12K - $12.1K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
500
|
$15.42 - $21.72
$7.71K - $10.9K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
84
|
$3.85 - $5.09
$323 - $428
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
110
|
$14.79 - $19.09
$1.63K - $2.1K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
175
|
N/A
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
450
|
N/A
|
|
Nuveen Select Tax Free Incom
|
Q3 2021
Filed on Nov 05, 2021
|
2,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
194
|
$42.53 - $64.54
$8.25K - $12.5K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
7,400
|
$3.89 - $11.66
$28.8K - $86.3K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
1,500
|
$24.86 - $35.02
$37.3K - $52.5K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
5,000
|
$2.36 - $3.32
$11.8K - $16.6K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
2,183
|
$19.68 - $22.51
$43K - $49.1K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
61
|
N/A
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
100
|
$21.96 - $27.79
$2.2K - $2.78K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
100
|
$13.6 - $17.88
$1.36K - $1.79K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
100
|
$45.91 - $59.67
$4.59K - $5.97K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
600
|
$10.3 - $13.45
$6.18K - $8.07K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
45
|
$18.42 - $19.75
$829 - $889
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
9
|
$2.15 - $3.82
$19.3 - $34.4
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
100
|
$1.97 - $2.67
$197 - $267
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
74
|
$52.88 - $57.05
$3.91K - $4.22K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
7,500
|
N/A
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
4,721
|
$17.06 - $25.59
$80.5K - $121K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
200
|
$12.95 - $18.24
$2.59K - $3.65K
|
|
Xeris Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 05, 2021
|
45
|
N/A
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
100
|
$7.26 - $23.03
$726 - $2.3K
|
|
Nisun Intl Ent Dvpmt Gp CO LTD Com Cl A
|
Q3 2021
Filed on Nov 05, 2021
|
500
|
N/A
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
500
|
$5.8 - $8.02
$2.9K - $4.01K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
31
|
$15.75 - $23.5
$488 - $729
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
297
|
$29.04 - $29.86
$8.62K - $8.87K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
15
|
$41.82 - $51.87
$627 - $778
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
586
|
$6.98 - $8.47
$4.09K - $4.96K
|
|
Inmed Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 05, 2021
|
151
|
N/A
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
248
|
N/A
|
|
Minerva Neurosciences Inc
|
Q3 2021
Filed on Nov 05, 2021
|
1,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
2
|
$3779.0 - $4254.6
$7.56K - $8.51K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
100
|
$36.52 - $40.4
$3.65K - $4.04K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
9,000
|
$1.87 - $2.57
$16.8K - $23.1K
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
36
|
$18.36 - $19.61
$661 - $706
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
40
|
$15.75 - $19.6
$630 - $784
|
|
|
Q3 2021
Filed on Nov 05, 2021
|
11
|
$34.57 - $39.06
$380 - $430
|
|